A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months

BACKGROUND: VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions. OBJECTIVE: To evaluate 12-month effectiveness and safety of VYC-17.5L for the treatment of moderate/severe nasolabial folds (NLFs). METHODS:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Dermatol Surg
Asıl Yazarlar: Sattler, Gerhard, Philipp-Dormston, Wolfgang G., Van Den Elzen, Helga, Van Der Walt, Cornelius, Nathan, Myooran, Kolodziejczyk, Julia, Kerson, Graeme, Dhillon, Benjeev
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414733/
https://ncbi.nlm.nih.gov/pubmed/28165349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/DSS.0000000000000939
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller